Krystexxa (Savient Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the Krystexxa drug offered from Savient Pharmaceuticals, Inc.. This Urate Oxidase [Chemical/Ingredient],Uric Acid-specific Enzyme [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Savient Pharmaceuticals, Inc. |
| NON-PROPRIETARY NAME: | pegloticase |
| SUBSTANCE NAME: | PEGLOTICASE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Urate Oxidase [Chemical/Ingredient],Uric Acid-specific Enzyme [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2010-09-14 |
| END MARKETING DATE: | 0000-00-00 |
Krystexxa HUMAN PRESCRIPTION DRUG Details:
| Item Description | Krystexxa from Savient Pharmaceuticals, Inc. |
| LABELER NAME: | Savient Pharmaceuticals, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 8(mg/mL) |
| START MARKETING DATE: | 2010-09-14 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 54396-801_8ec18670-b429-432f-b7c5-7a43fd397c47 |
| PRODUCT NDC: | 54396-801 |
| APPLICATION NUMBER: | BLA125293 |
Other PEGLOTICASE Pharmaceutical Manufacturers / Labelers:
